Ci-Tu MedScience GmbH delivers comprehensive medical scientific consulting services, combining deep scientific expertise with strategic insight to advance the initiatives of pharmaceutical companies and CROs.
Comprehensive medical scientific consulting solutions tailored to the pharmaceutical companies and CROs
Strategic, end-to-end leadership across clinical development and evidence generation—from study design and execution to regulatory alignment—delivering high-quality, submission-ready outputs.
Strategic, end-to-end leadership for real-world evidence—from research question and study design to data sourcing, analytics, and regulatory alignment. To help teams generate decision-ready insights using fit-for-purpose methods and high-quality deliverables.
Strategic, end-to-end leadership and oversight of drug safety across the product lifecycle—from safety strategy to regulatory alignment, including assessment of safety data to identify, evaluate, and manage emerging safety signals.
Strategic leadership bridging clinical evidence and real-world practice—shaping scientific narrative, stakeholder engagement, and medical strategy across the product lifecycle. To support teams with high-level guidance and oversight to ensure medical plans are credible, compliant, and impact-focused.
Evidence-based strategies for optimal market positioning and reimbursement
High-level guidance on therapeutic development and portfolio optimization
Practical coaching for leaders and teams to improve decision-making, communication, and execution under uncertainty—plus high-level coaching for pharma executives, medical leaders, and life-science teams to sharpen scientific judgment and strategic thinking, turning complex evidence into clear decisions.
Strategic guidance and hands-on support to design, build, and scale digital health products—combining clinical insight, behavioral science, and data-driven development.
Guided by deep scientific expertise and extensive pharmaceutical industry experience
Founder & Principal Consultant
Dr. Cigdem Turkmen is a medical science consultant specializing in Clinical Development, Medical Affairs, and Real-World Evidence (RWE) strategy. A board-certified neurologist with a Master's degree in Movement Disorders, she brings deep scientific rigor to pharmaceutical consulting.
Her robust industry background includes over 15 years of leadership at major global organizations such as Novartis, Merck, Abbott, and Roche. Throughout her career, she has successfully led global therapeutic area review committees, managed cross-functional matrix teams, and oversaw clinical trials across diverse regions.
Dr. Turkmen partners with pharmaceutical companies and CROs to optimize medical strategies, ensure GCP compliance, and accelerate evidence generation for complex therapeutic areas, including CNS and rare diseases.
Partner with Ci-Tu MedScience GmbH to advance your medical science initiatives with expert guidance and strategic insight.